GlassScriptPhysician profile
Sudeshna Dutta
NPI 1073184735
$909.24
in general payments reported to CMS, 2019-2025
16 companies · $571 in 2025
The $571 reported for 2025 was more than what 76% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $23.91 · 2022: $39.28 · 2023: $38.44 · 2024: $236 · 2025: $571.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $846.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $846.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $268.84 | 2021-2025 | |
| Viiv Healthcare Company | $201.17 | 2024-2025 | Dovato, Apretude |
| Merck Sharp & Dohme LLC | $74.76 | 2024-2025 | Pifeltro, Delstrigo |
| Pfizer INC. | $60.34 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $51.04 | 2023-2025 | |
| Inspire Medical Systems, INC. | $45.97 | 2025 | Inspire |
| Astrazeneca Pharmaceuticals LP | $31.32 | 2024-2025 | Breztri, Airsupra |
| Lilly USA, LLC | $27.97 | 2025 | Mounjaro, Zepbound |
| Astellas Pharma US INC | $27.05 | 2025 | Veozah |
| Sanofi-Aventis U.S. LLC | $20.56 | 2025 | |
| Janssen Biotech, INC. | $20.56 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.72 | 2022 | |
| Seqirus USA INC | $17.98 | 2025 | Flucelvax, Fluad |
| Lexicon Pharmaceuticals, INC. | $14.80 | 2024 | |
| Organon LLC | $14.47 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $13.69 | 2024 | Ingrezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sudeshna Dutta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.